The extended administration of GnRH agonist prior to ART treatment to improve live birth rate in infertile women with endometriosis is not recommended, as the benefit is uncertain (Georgiou et al., 2019; Cao et al., 2020; Kaponis et al., 2020). |
|
There is insufficient evidence to recommend prolonged administration of the combined oral contraceptives (COC)/progestogens as a pre-treatment to ART to increase live birth rates (de Ziegler et al., 2010). |
|